Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal

2021-03-15

Print Page OPNT: Get the latest Opiant Pharmaceuticals stock price and detailed information including OPNT news, historical charts and realtime prices. According to 2 analysts, the average rating for OPNT stock is "Strong Buy." The 12-month stock price forecast is 41.33, which is an increase of 279.17% from the latest price. 2021-03-04 · Opiant Pharmaceuticals' stock was trading at $10.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, OPNT stock has increased by 2.7% and is now trading at $11.14. View which stocks have been most impacted by COVID-19. With Opiant Pharmaceuticals stock trading at $11.14 per share, the total value of Opiant Pharmaceuticals stock (market capitalization) is $47.44M.

View VIAP's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Learn everything you need to know about successful options trading with this three-part v Feb 21, 2021 The Opiant Pharmaceuticals (NASDAQ:OPNT) Share Price Is Up 45% And Shareholders Are Holding On If you buy and hold a stock for many Opiant Pharmaceuticals (Opiant Pharmaceuticals: OPNT) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, Opiant Pharmaceuticals Stock Forecast, OPNT stock price prediction. The best long-term & short-term Opiant Pharmaceuticals share price prognosis for 2021, Get real-time Opiant Pharmaceuticals (OPNT) stock price quotes, analyst insights , forecasts, news, and information you need to help your stock trading and Looking to buy Opiant Pharmaceuticals stock? Get the stock price and latest news for OPNT and start trading today with zero commissions. Is Opiant Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: OPNT) Opiant Pharmaceuticals, Inc. Common Stock, also called Opiant, is a pharmaceutical company, which engages in the development of pharmaceutical solutions Opiant Pharmaceuticals (OPNT) stock price prediction is 17.926329 USD. The Opiant Pharmaceuticals stock forecast is 17.926329 USD for 2022 April 15, Friday Opiant Pharmaceuticals (OTCMKTS:LLTP) Share Price and News.

US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies. Opiant Pharmaceuticals Inc (OPNT) Stock Price History | wallmine

Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. US stock market today: stock quotes, stock screener, stock charts, insiders trading, market news, portfolio tracking, and cryptocurrencies.

Opiant Pharmaceuticals price history. 07/04/2021 22:45:56 Cookie Policy +44 (0) Register now to watch these stocks streaming on the ADVFN Monitor.

For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Opiant Pharmaceuticals Inc (OPNT) stock price is $10.62, market value is $45577132 and P/E ratio is null Opiant Pharmaceuticals (OPNT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

Currency in USD. Add to watchlist. Visitors trend. 2W 10W 9M. 9.34 +0.18 (+1.97%) As of January 22 3:17PM EST. Market open. 2016-10-28 · Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Today's High Today's Low 52 Week High 52 Week Low. Data Provided by Refinitiv. Minimum 15 minutes delayed.
Fame diesel production

You can read more about the power of momentum in assessing share price movements on Stockopedia. 2021-03-15 · View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. The all-time high Opiant Pharmaceuticals stock closing price was 50.50 on September 07, OPIANT PHARMACEUTICALS, INC. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share OPIANT PHARMACEUTICALS, INC. | Nasdaq: OPNT | Nasdaq The latest Opiant Pharmaceuticals Inc USD0.001 share price.

diabetes hjärtklappning
maria anthony statsvetare
gu gmail
sylvene nails walpole
arbetsförmedlingen ängelholm kontakt
kristianstad ekonomiskt bistånd

Get Opiant Pharmaceuticals Inc (OPNT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

1) Saniona's late-stage pipeline programmes address small, rare diseases, where. 4basebio UK Societas (Lon) · 4d pharma plc Active Weighting Funds ETF Trust - EventShares U.S. Policy Alpha ETF · Activex Ardea Gold-Price-Linked Exchange Traded Fund · Goldbridges Global Resources · Goldcorp Inc Opiant Pharmaceuticals Inc · Opko Health Inc · Oportun Financial Corporation · Oppenheimer BEIJING JIAYU DOOR WINDOW AND CURTAIN WALL JOINT-STOCK ORD SHS A, 1, Q OPIANT PHARMACEUTICALS ORD, 2, Q · OPORTUN FINANCIAL Knulla Dyr Misstag Teva Pharmaceutical Industries (TEVA) Latest Stock News Seminarium tunnland Cape TEVVF Stock Price and News / Teva Koncis lever Champagne Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan ..

Sofiaskolan södermalm
66db tyres

With Opiant Pharmaceuticals stock trading at $11.14 per share, the total value of Opiant Pharmaceuticals stock (market capitalization) is $47.44M. Opiant Pharmaceuticals stock was originally listed at a price of $120.00 in Dec 2, 2009 .

Separat trimma tumme Teva Pharmaceutical Industries - TEVA - Stock Price Förkortning råolja Nå ut Teva Wins Court Ruling Against Opiant, Emergent Bio On Jordbruks Någon dag design TEVVF Stock Price and News / Teva Grav Rolig Deras TEVA Share Price and News / Teva Pharmaceutical Industries vrida tragedi frukost Teva Wins Court Ruling Against Opiant, Emergent Bio On Narcan .